Summarized by Masters of Longevity from FDA - Press Releases.
Non-animal safety testing for drugs and biologics: a policy-focused explainer showing how regulators are updating rules and what readers should expect to learn.
Key Takeaways
- The FDA issued a direct final rule allowing non-animal methods for preclinical safety testing when appropriate.
- The rule explicitly applies to drugs and biological products intended for human use prior to human testing.
- Regulators will accept innovative alternative methods as valid evidence in lieu of animal tests under this framework.
